Thursday, February 7, 2013
This week in
HCV NS3/4A protease complex
identified a macrocyclic acyl sulfonamide-based
inhibitor of HCV NS3/4A protease that could help treat drug-resistant HCV
infection. In a panel of enzyme inhibition assays, the compound inhibited the
NS3/4A protease from 13 HCV strains, including 6 with known resistance
mutations, at nanomolar and subnanomolar concentrations. The inhibitor also
showed no activity in a panel of seven off-target proteases and had low
cytotoxicity in a human hepatocyte cell line. Next steps could include
testing the lead inhibitor in models of HCV infection.
Pharmaceuticals Inc. markets Incivek
telaprevir, a small molecule HCV NS3/4A protease inhibitor, to
treat HCV infection.
& Co. Inc. markets Victrelis
boceprevir, a small molecule HCV NS3/4A protease inhibitor, for
Ingelheim GmbH's faldaprevir, an oral HCV NS3/4A
protease inhibitor, is in Phase III testing to treat HCV infection.
At least six other companies have inhibitors of the HCV NS3/4A protease in
Phase III testing or earlier to treat HCV infection.
Published online Feb. 7, 2013
Patent and licensing status
O'Meara, J.A. et al. J.
Biol. Chem.; published online Dec. 27, 2012;
Contact: Jeff A. O'Meara, Boehringer Ingelheim Ltd. R&D,
Laval, Quebec, Canada
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]